Cellnovo
Founded Year
2002Stage
IPO | IPOTotal Raised
$48.4MDate of IPO
7/9/2015About Cellnovo
Cellnovo Group, an independent medical technology company specialising in diabetes, Cellnovo has developed and markets the first connected all-in-one diabetes management system that helps make life easier for patients. Compact, tubeless, intuitive and entirely connected, Cellnovo's insulin pump comprises a mobile touchscreen controller with an integrated blood-glucose meter. With Cellnovo's device, certain aspects of diabetes management still require an action from the patient (blood glucose monitoring and injection of insulin just before meals). This unique device allows optimal management of insulin injections whilst ensuring extensive freedom of movement and peace of mind for patients. Thanks to the automatic transmission of data, it also allows the patient's condition to be continually monitored by family members and healthcare professionals in real-time.
Missing: Cellnovo's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Cellnovo's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Cellnovo
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Cellnovo is included in 4 Expert Collections, including Medical Devices.
Medical Devices
8,633 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Diabetes
1,904 items
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Health IT
7,901 items
Cellnovo Patents
Cellnovo has filed 10 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/30/2015 | 10/22/2019 | Diabetes, Insulin therapies, Blood tests, Sensors, Syndromes | Grant |
Application Date | 1/30/2015 |
|---|---|
Grant Date | 10/22/2019 |
Title | |
Related Topics | Diabetes, Insulin therapies, Blood tests, Sensors, Syndromes |
Status | Grant |
Latest Cellnovo News
Apr 5, 2021
Record Identify: Global Insulin Pumps Marketplace 2020 International Trade Measurement Analyzed through Trade Alternative, Construction, Expansion Elements, Programs Research and Long term Possibilities 2020 International Insulin Pumps Marketplace file provides whole and clever research of the festival, segmentation, dynamics, and geographical development with long run trade prospect to 2024. The analysis learn about has been ready with using in-depth qualitative and quantitative analyses of the worldwide Insulin Pumps marketplace. We now have additionally supplied absolute buck alternative and different sorts of marketplace research at the international Insulin Pumps marketplace. This file comprises present developments, enlargement components, alternatives, and marketplace restraints. The Corporate Protection of Insulin Pumps marketplace is as in keeping with under (Gross sales Income, Value, Gross Margin, Primary Merchandise and many others. ): Medtronic, Cellnovo Team SA, F. Hoffmann-Los angeles Roche Ltd., Animas Company (Johnson& Johnson), Valeritas, Inc., Tandem Diabetes Care, Inc., SOOIL Traits Co., Ltd, Insulet Company, Ypsomed A Obtain Unfastened Pattern Replica of Insulin Pumps Marketplace Record: https://www.esherpamarketreports.com/request-sample/es-75366/ Goal Target market of Insulin Pumps Marketplace 2020 Forecast to 2024 Marketplace: Producer / Doable Traders Affiliation and executive our bodies. The content material of the learn about topics, features a overall of 15 chapters: Bankruptcy 1, to explain Insulin Pumps product scope, marketplace evaluate, marketplace alternatives, marketplace driver and marketplace dangers. Bankruptcy 2, to profile the highest producers of Insulin Pumps, with worth, gross sales, income and international marketplace proportion of Insulin Pumps in 2017 and 2018. Bankruptcy 3, the Insulin Pumps aggressive scenario, gross sales, income and international marketplace proportion of best producers are analysed emphatically through panorama distinction. Bankruptcy 4, the Insulin Pumps breakdown information are proven on the regional degree, to turn the gross sales, income and enlargement through areas, from 2014 to 2020. Bankruptcy 5, 6, 7, 8 and 9, to damage the gross sales information on the nation degree, with gross sales, income and marketplace proportion for key international locations on the planet, from 2014 to 2020. Bankruptcy 10 and 11, to phase the gross sales through sort and alertness, with gross sales marketplace proportion and enlargement charge through sort, utility, from 2014 to 2020. Bankruptcy 12, Insulin Pumps marketplace forecast, through areas, sort and alertness, with gross sales and income, from 2020 to 2024. Bankruptcy 13, 14 and 15, to explain Insulin Pumps gross sales channel, vendors, consumers, analysis findings and conclusion, appendix and information supply. Enquire extra or proportion questions if any sooner than the acquisition on Insulin Pumps file – https://www.esherpamarketreports.com/pre-order-enquiry/es-75366/ At the foundation of the top customers/packages, this Insulin Pumps marketplace file specializes in the standing and outlook for primary packages/finish customers, intake (gross sales), Insulin Pumps trade proportion and enlargement charge for every utility, together with: Utility 1 Utility 3 At the foundation of product, this file presentations the manufacturing, income, worth, Insulin Pumps marketplace proportion and enlargement charge of every sort, basically break up into: Sort 1 North The usa (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South The usa (Brazil, Argentina, Columbia and many others.) Center East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Causes to shop for Insulin Pumps Marketplace Record: – Assists corporations to make efficient trade technique selections through understanding the Insulin Pumps marketplace prerequisites and sentiment inside the Marketplace. Helps organizations in trade growth selections through offering data regarding the projected variation in gross sales efficiency and provider costs. Is helping IT enterprises in aligning themselves with the most recent marketplace developments and Insulin Pumps sentiments through informing them with the very important priorities and primary issues of the trade. Serves to regulate funding allocation through outlining key focal point spaces highlighted through survey respondents all through 2020. Acquire this Record with Complete Get right of entry to & Entire ToC at – https://www.esherpamarketreports.com/acquire/es-75366/ This Insulin Pumps Marketplace Analysis/research Record Accommodates Solutions in your following questions Which Production Generation is Used for Insulin Pumps? What Traits Are Going On in That Generation? Which Tendencies Are Inflicting Those Traits? Who Are the International Key Avid gamers in This Insulin Pumps Marketplace? What’s Their Corporate Profile, Their Product Data, Touch Data? What Used to be International Marketplace Standing of Insulin Pumps Marketplace? What Used to be Capability, Manufacturing Worth, Value and PROFIT of Insulin Pumps Marketplace? What Is Present Marketplace Standing of Insulin Pumps Marketplace? What’s Marketplace Pageant in This Trade, Each Corporate and Nation Sensible? What’s Marketplace Research of Insulin Pumps Marketplace through Taking Programs and Varieties in Attention? What Are Projections of International Insulin Pumps Marketplace Making an allowance for Capability, Manufacturing and Manufacturing Worth? What Will Be Estimation of Value and Benefit? What Will Be Marketplace Percentage, Provide and Intake? What About Import and Export? What Is Insulin Pumps Marketplace Chain Research through Upstream Uncooked Fabrics and Downstream Trade? What Is Financial Affect On Insulin Pumps Marketplace? What are International Macroeconomic Atmosphere Research Effects? What Are International Macroeconomic Atmosphere Construction Tendencies? What Are Marketplace Dynamics of Insulin Pumps Marketplace? What Are Demanding situations and Alternatives? What Must Be Access Methods, Countermeasures to Financial Affect, Advertising and marketing Channels for Insulin Pumps Marketplace? About Us: eSherpa Marketplace Studies is the credible supply for gaining the marketplace analysis reviews that may exponentially boost up your online business. We’re some of the main file resellers within the trade global dedicated against optimizing your online business. The reviews we offer are in line with a analysis that covers a magnitude of things reminiscent of technological evolution, financial shifts and an in depth learn about of marketplace segments.
Cellnovo Frequently Asked Questions (FAQ)
When was Cellnovo founded?
Cellnovo was founded in 2002.
Where is Cellnovo's headquarters?
Cellnovo's headquarters is located at Rue de Londres, 26-28, Paris.
What is Cellnovo's latest funding round?
Cellnovo's latest funding round is IPO.
How much did Cellnovo raise?
Cellnovo raised a total of $48.4M.
Who are the investors of Cellnovo?
Investors of Cellnovo include NBGI Ventures, Andera Partners, Nesta, Advent Life Sciences, Auriga and 4 more.
Who are Cellnovo's competitors?
Competitors of Cellnovo include Mirus Bio, Erydel, Medipacs, Iontera, Intercell and 11 more.
Compare Cellnovo to Competitors
EryDel develops a red-blood-cell-based drug delivery device for the treatment of rare neurodegenerative diseases. Its proprietary technology relies upon the encapsulation of drugs into red cells taken from the patient's own blood, which are then re-infused into the patient.
Tandem is a medical device company located in San Diego. The company manufactures and sells an automated drug delivery system primarily for use in home-administered IV's. The device is a relatively simple mechanical pump that is simpler and safer to use than standard IV therapy.
Next Breath, LLC is a contract pharmaceutical research and development organization dedicated to pre-clinical identification and evaluation of commercially viable respiratory and nasal drug delivery platforms. NB's business will discover and exploit optimal drug and delivery device combinations that will increase the company's partners' probability of success when their products advance into human clinical trials and the marketplace. Next Breath seeks to meet the pharmaceutical industry's outsourcing needs and to provide intellectual expertise to biotechnology companies that are developing inhalation products.
Therataxis LLC models brain transport processes and designs delivery methods for therapies. The simulation and prediction of transport mechanisms, and their direct delivery devices, provide the necessary link in developing successful therapies of the brain by ensuring proper delivery. Their currently marketed products are surgical simulation software and simulation-based device designs.
Vapore is the developer of MyPurMist, a device that provides soothing hot steam on demand. The directed humidification (vapor) of MyPurMist brings warmth into the sinuses which thins mucus and makes breathing easier. The moisture in the mist helps to relieve symptoms by soothing irritated tissues in the nose and throat, calming coughs and reducing dryness.
Talima Therapeutics is an emerging drug delivery company dedicated to the development of novel products that increase patient choice and improve quality of life. With a unique approach to therapy, we design customized drug-delivery systems that optimize the local therapeutic performance and reduce the undesired systemic side effects enabling us to address unmet needs or underserved markets. We foster a collaborative environment and strive for excellence internally and with our partners. Our lead product is currently in Phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the nails and we are in the process of planning its pivotal trials.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.